ID Source | ID |
---|---|
PubMed CID | 65164 |
SCHEMBL ID | 7102956 |
MeSH ID | M0079453 |
Synonym |
---|
1-methylisatin-.beta.-4':4'-diethylthiosemicarbazone |
m-ibdet |
1,1-diethyl-3-[(z)-(1-methyl-2-oxo-indolin-3-ylidene)amino]thiourea |
n-methylisatin beta-4',4'-diethylthiosemicarbazone |
unii-241z264jmn |
hydrazinecarbothioamide, 2-(1,2-dihydro-1-methyl-2-oxo-3h-indol-3-ylidene)-n,n-diethyl- |
6452-15-9 |
241z264jmn , |
SCHEMBL7102956 |
indole-2,3-dione, 1-methyl-, 3-(4,4-diethyl-3-thiosemicarbazone) |
2-(1,2-dihydro-1-methyl-2-oxo-3h-indol-3-ylidene)-n,n-diethylhydrazinecarbothioamide |
Q27896472 |
1,1-diethyl-3-(2-hydroxy-1-methylindol-3-yl)iminothiourea |
AKOS040753297 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |